ACLX - Financial Reports List - Arcellx, Inc. - IntrinsicAlpha

Arcellx, Inc. ACLX

Healthcare - Biotechnology - NASDAQ - US

$ 56.65

-3.31 %

$ 3.11 B

Market Cap

-28.32

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-75.83%	-237.26%	-354.37%
Annual Report	FY	10-K	2024-12-31	-2.16%	-51.86%	-53.06%
Quarterly Report	Q3	8-K	2024-09-30	74.03%	34.24%	25.07%
Quarterly Report	Q2	8-K	2024-06-30	91.47%	-14.04%	-18.38%
Quarterly Report	Q1	8-K	2024-03-31	119.16%	73.36%	48.09%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	150.89%	137.49%
Annual Report	FY	10-K	2023-12-31	0.00%	62.01%	53.01%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	57.65%	52.21%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	22.48%	5.53%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	16.58%	6.10%

1